Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prognostic Stage IIIA Breast Cancer AJCC v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01194440
What this trial is testing

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Who this might be right for
Ductal Carcinoma in SituEstrogen Receptor-positive Breast CancerProgesterone Receptor-positive Breast Cancer+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Not applicableStudy completedNCT00283608
What this trial is testing

Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 1,000
Large-scale testing (Phase 3)Temporarily pausedNCT00002696
What this trial is testing

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

Who this might be right for
Breast Cancer
Grupo Oncologico Cooperativo del Sur
Not applicableStudy completedNCT00416754
What this trial is testing

Genetic Counseling in Women at Risk for BRCA1 or BRCA2 Mutations

Who this might be right for
Breast Cancer
Georgetown University 1,109
Large-scale testing (Phase 3)UnknownNCT00072020
What this trial is testing

Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
University of Sheffield
Early research (Phase 1)Study completedNCT00009997
What this trial is testing

Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
NYU Langone Health
Not applicableStudy completedNCT00486525
What this trial is testing

Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer Survivors

Who this might be right for
Breast CancerDepressionFatigue+1 more
Ohio State University Comprehensive Cancer Center 200
Large-scale testing (Phase 3)Study completedNCT02003209
What this trial is testing

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

Who this might be right for
HER2-Positive Breast CarcinomaHormone Receptor-Positive Breast CarcinomaStage IB Breast Cancer AJCC v7+5 more
National Cancer Institute (NCI) 315
Not applicableStudy completedNCT02702830
What this trial is testing

MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment

Who this might be right for
Healthy SubjectStage IA Breast CancerStage IB Breast Cancer+5 more
Wake Forest University Health Sciences 33
Not applicableStudy completedNCT03505671
What this trial is testing

Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+21 more
Wake Forest University Health Sciences 23
Large-scale testing (Phase 3)Study completedNCT01598298
What this trial is testing

S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy

Who this might be right for
Breast CancerMusculoskeletal ComplicationsPain
SWOG Cancer Research Network 299
Not applicableStudy completedNCT00343863
What this trial is testing

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

Who this might be right for
Male Breast CancerNausea and VomitingStage I Breast Cancer+2 more
University of Washington 41
Not applicableUnknownNCT01286233
What this trial is testing

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Who this might be right for
Breast CancerDepressionFatigue+1 more
NSABP Foundation Inc 394
Testing effectiveness (Phase 2)Study completedNCT00005798
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 209
Not applicableStudy completedNCT00897299
What this trial is testing

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

Who this might be right for
Breast CancerEstrogen ReceptorHer-2+1 more
Eastern Cooperative Oncology Group 900
Testing effectiveness (Phase 2)Active Not RecruitingNCT03971409
What this trial is testing

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

Who this might be right for
Stage III Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+6 more
Laura Huppert, MD, BA 145
Testing effectiveness (Phase 2)Study completedNCT00295867
What this trial is testing

Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Francisco 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT01334021
What this trial is testing

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
M.D. Anderson Cancer Center 1,100
Early research (Phase 1)Ended earlyNCT01238133
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+6 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Ended earlyNCT02273752
What this trial is testing

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more
Emory University 2
Next Page